CRYOPORT, INC. Inventory, Finished Goods, Gross
CRYOPORT, INC. (CYRX) had Inventory, Finished Goods, Gross of $10.41 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Assets › Assets, Current › Inventory, Net
us-gaap:InventoryFinishedGoods · last filed 2023-08-09
- 2023-06-30: Inventory, Finished Goods, Gross $10.41M.
- 2023-03-31: Inventory, Finished Goods, Gross $9.65M.
- 2022-12-31: Inventory, Finished Goods, Gross $8.50M.
- 2022-09-30: Inventory, Finished Goods, Gross $6.40M.
| Period end | Inventory, Finished Goods, Gross | Inventory, Finished Goods, Gross as first filed |
|---|---|---|
| 2023-06-30 | $10.41M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $9.65M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $8.50M 10-Q · filed 2023-08-09 | |
| 2022-09-30 | $6.40M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $6.44M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $6.10M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $3.98M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $2.66M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $2.48M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $2.92M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $2.76M 10-K · filed 2022-02-28 | |
| 2019-12-31 | $117.00K 10-K · filed 2021-03-01 | $117.25K 10-K · filed 2020-03-10 |
| 2018-12-31 | $96.99K 10-K · filed 2020-03-10 | |
| 2017-12-31 | $10.05K 10-K · filed 2019-03-13 | |
| 2016-12-31 | $30.84K 10-K · filed 2018-03-08 | |
| 2016-03-31 | $12.88K 10-KT · filed 2017-03-13 | |
| 2015-03-31 | $27.95K 10-K · filed 2016-06-28 | |
| 2014-03-31 | $11.42K 10-K · filed 2015-05-19 | |
| 2013-03-31 | $10.68K 10-K · filed 2014-06-25 | |
| 2012-03-31 | $19.20K 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |